{
|
"batch_id": "BATCH-STOCK-VALUATION-CURRENT-RESEARCH-20260820-001",
|
"ticker": "603077.SH",
|
"company": "和邦生物",
|
"as_of": "2026-08-19",
|
"v2_status": "BLOCKED",
|
"v2_failure": {
|
"complete": false,
|
"error": "ValueError: E_HISTORICAL_SHARES_UNPROVEN：quote f124 缺失或为 0",
|
"error_code": "E_CORE_INPUT",
|
"error_type": "CoreInputError",
|
"recorded_at": "2026-08-20T15:18:53.687+08:00",
|
"rollback_errors": [],
|
"run_id": "c2ad41734a264967942ff47e895a1ee5",
|
"schema_version": 2,
|
"status": "BLOCKED"
|
},
|
"v2_runtime_package": "v2_603077_SH.failed-c2ad41734a264967942ff47e895a1ee5",
|
"v2_raw_artifact_hashes": [
|
"0fe35f5fb9b8ba68c2b02106b17a2d86c1c95953a278aa76948edf1fcb51ce99",
|
"114ddc7e77eb1011e7ce9fb2c7ae56b599e5422847c11c17fd995567bb9a888b",
|
"1bd7ea44f3e9d968413970271da8b5dcaf3c3db43b3f4b31cc2d5e169232f56e",
|
"27a3a92e99a0ad9f85709342b369b864bed1f9cf25f8cd570d3e90fc7b8a3d3c",
|
"4ed16e9dbab91d9707c8d3f4ebba2c8757a5324badaba50ca8e091b28bc47ca7",
|
"56fc8163ba5716ddcc09c246fd75eb491959863835f2dd9b575710f285728196",
|
"61bf17d76be1aacb5823824329b97e149c073be4c8c3fde55a083888e2d59109",
|
"6ff0b402155f56d01311227f154a7d712e672584c942ce7d23229e0189ea6d87",
|
"d185f95f6b34522dd96f38d3d5509a2f665356f53b53104caae0540ccd3543fa",
|
"e0674e1735a70c061fd9625b8bf2a9be3de91df40f6489993220b1d0f241f749"
|
],
|
"market_contract": {
|
"table": "trading_xuntou.cn_stock_kline_1d_front",
|
"source": "xtquant",
|
"source_batch_id": "FKL_20260819_161003_75ac38b0_1d_20260819_00014",
|
"updated_at": "2026-08-19 16:28:14",
|
"trade_date": "2026-08-19"
|
},
|
"quote_raw_hash": "56fc8163ba5716ddcc09c246fd75eb491959863835f2dd9b575710f285728196",
|
"share_proof": {
|
"shares": 8831705728.0,
|
"shares_fallback": false,
|
"shares_fallback_source": "eastmoney.market:f84",
|
"report_shares": 8831702728.0,
|
"share_unit_correction": null,
|
"static_total_shares": 8831537228.0,
|
"match_report": true,
|
"quote_market_cap": 21019459632.64,
|
"price_times_shares": 20754508460.8,
|
"gap_rate": 0.012765957446808519
|
},
|
"industry_membership": {
|
"industries": [
|
"农业"
|
],
|
"layers": [
|
"FERTILIZER:B_GROUP_OVERSEAS_REVENUE_PROXY"
|
],
|
"research_name": "和邦生物"
|
},
|
"bounded_gaps": [
|
"V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
|
"机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
|
],
|
"checks": {
|
"v1_qa": {
|
"error_count": 0,
|
"info_count": 0,
|
"issues": [
|
{
|
"action": "使用正常化情景、PB 或反向估值。",
|
"field": "metrics.ttm_attributable_profit",
|
"issue_id": "QA-NEGATIVE-TTM-PROFIT",
|
"message": "TTM 归母利润不为正，报告 PE 不适用。",
|
"recalc_scope": "PE 模块",
|
"severity": "WARNING"
|
},
|
{
|
"action": "检查主营盈利恢复条件。",
|
"field": "metrics.ttm_deduct_profit",
|
"issue_id": "QA-NEGATIVE-TTM-DEDUCT",
|
"message": "TTM 扣非利润不为正，扣非 PE 不适用。",
|
"recalc_scope": "扣非 PE 模块",
|
"severity": "WARNING"
|
},
|
{
|
"action": "拆解营运资本、资本开支与回款持续性。",
|
"field": "metrics.annual_fcf",
|
"issue_id": "QA-NEGATIVE-FCF",
|
"message": "最近完整年度简化自由现金流为负。",
|
"recalc_scope": "DCF 与现金流交叉验证",
|
"severity": "WARNING"
|
}
|
],
|
"status": "PASS_WITH_WARNINGS",
|
"warning_count": 3
|
},
|
"label": "基本合理",
|
"base_low": 1.1154000000000002,
|
"base_high": 2.9250000000000003,
|
"optimistic_high": 5.830500000000001,
|
"price": 2.35,
|
"bubble_status": "未识别估值泡沫"
|
}
|
}
|
